iRhythm Holdings (IRTC) EBITDA Margin (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -921.00 |
| Dec 31, 2025 | 546.00 |
| Sep 30, 2025 | 565.00 |
| Jun 30, 2025 | 1,050.00 |
| Mar 31, 2025 | -1,803.00 |
| Dec 31, 2024 | 3,161.00 |
| Sep 30, 2024 | -1,857.00 |
| Jun 30, 2024 | 1,339.00 |
| Mar 31, 2024 | 66.00 |
| Dec 31, 2023 | -742.00 |
| Sep 30, 2023 | -695.00 |
| Jun 30, 2023 | 2,025.00 |
| Mar 31, 2023 | -1,707.00 |
| Dec 31, 2022 | 192.00 |
| Sep 30, 2022 | 268.00 |
| Jun 30, 2022 | 2,958.00 |
| Mar 31, 2022 | -1,319.00 |
| Dec 31, 2021 | -1,211.00 |
| Sep 30, 2021 | -635.00 |
| Jun 30, 2021 | 1,606.00 |
| Mar 31, 2021 | -2,481.00 |
| Dec 31, 2020 | -555.00 |
| Sep 30, 2020 | 3,302.00 |
| Jun 30, 2020 | -2,519.00 |
| Mar 31, 2020 | 1,555.00 |
| Dec 31, 2019 | 341.00 |
| Sep 30, 2019 | -1,325.00 |
| Jun 30, 2019 | -317.00 |
| Mar 31, 2019 | 1,436.00 |
| Dec 31, 2018 | -734.00 |
| Sep 30, 2018 | 1,223.00 |
| Jun 30, 2018 | -285.00 |
| Mar 31, 2018 | 546.00 |
| Dec 31, 2017 | -1,493.00 |
| Sep 30, 2017 | 92.00 |
| Jun 30, 2017 | -269.00 |
| Mar 31, 2017 | 111.00 |
| Dec 31, 2016 | -736.00 |
| Sep 30, 2016 | 761.00 |
| Jun 30, 2016 | 1,440.00 |
| Mar 31, 2016 | 2,562.00 |
| Dec 31, 2015 | -465.00 |